Discovering a new world of therapeutics

The therapeutic potential of the human transcriptome, the set of all RNAs transcribed from DNA, remains largely unexplored. By harnessing new insights into RNA structure and dynamics, Arrakis is opening the transcriptome to therapy by small-molecule medicines to treat patients not cured by today’s medicines. We aim to unlock the therapeutic potential of deeply researched, valuable targets and to identify new disease intervention points that may be uniquely addressed with RNA-targeted small molecules.

Targeting RNA – Lessons Learned from Oligos
May 08, 2018
James Barsoum, PhD
The Rime of the Ancient Medicinal Chemist: Structure, Structure Everywhere
Apr 20, 2018
Russ Petter, PhD
Drug-Likeness and RNA-Targeted Small Molecules
Mar 13, 2018
Thomas Hermann
Back to Top